Thomas Crabbe
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 15
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 8
- Immunology and Allergy top 2%
- Oncology top 5%
- Peptidase Inhibition and Analysis 12
- Biotechnology top 5%
- Enzyme Production and Characterization 4
-
- PI3K/AKT/mTOR signaling in cancer 2
- Enzyme Catalysis and Immobilization 1
- Protein Kinase Regulation and GTPase Signaling 1
-
- Intraocular Surgery and Lenses 1
- Co-authors
- Gillian MurphyAndrew DochertySusan J. AtkinsonMichael J. ButlerJames P. O’ConnellFrances WillenbrockGeorgina S. ButlerTatsuya Tamura
- Partner nations
- United KingdomCanadaGermany
In The Last Decade
Thomas Crabbe
20 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 1.5k
- Hematology 669
- Immunology and Allergy 332
- Oncology 961
- Biotechnology 113
Countries citing papers authored by Thomas Crabbe
This map shows the geographic impact of Thomas Crabbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Crabbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Crabbe more than expected).
Fields of papers citing papers by Thomas Crabbe
This network shows the impact of papers produced by Thomas Crabbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Crabbe. The network helps show where Thomas Crabbe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Crabbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 122 | |
| 2 | 2007 | 11 | |
| 3 | 2005 | 54 | |
| 4 | 2003 | 23 | |
| 5 | The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase Abreakdown → | 1998 | 510 |
| 6 | 1998 | 23 | |
| 7 | Matrix metalloproteinases and metastatic cancer. | 1998 | 108 |
| 8 | 1996 | 75 | |
| 9 | 1996 | 18 | |
| 10 | 1996 | 6 | |
| 11 | 1995 | 10 | |
| 12 | 1995 | 217 | |
| 13 | 1995 | 162 | |
| 14 | 1994 | 82 | |
| 15 | 1994 | 59 | |
| 16 | 1994 | 82 | |
| 17 | 1994 | 183 | |
| 18 | 1993 | 206 | |
| 19 | 1993 | 90 | |
| 20 | 1992 | 75 |
About Thomas Crabbe
Thomas Crabbe is a scholar working on Cancer Research, Hematology, Biotechnology, Oncology and Orthodontics, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (15 papers), Peptidase Inhibition and Analysis (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Enzyme Production and Characterization (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Enzyme Catalysis and Immobilization (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper) and Intraocular Surgery and Lenses (1 paper). The work is most often cited by research in Cancer Research (1.5k citations), Hematology (669 citations), Immunology and Allergy (332 citations), Oncology (961 citations) and Biotechnology (113 citations). Thomas Crabbe has collaborated with scholars based in United Kingdom, Canada and Germany. Frequent co-authors include Gillian Murphy, Andrew Docherty, Susan J. Atkinson, Michael J. Butler, James P. O’Connell, Frances Willenbrock, Georgina S. Butler, Tatsuya Tamura, Horst Will and Marie‐Pia d’Ortho. Their work appears in journals such as Biochemistry, FEBS Letters, Journal of Biological Chemistry, Journal of Pharmaceutical Sciences and Alcohol and Alcoholism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.